iwAL 2018 day 1 discussion: treatment strategies in pediatric and adult ALL
Charles Mullighan et al.
Clinically relevant side effects of BiTE immunotherapy and other T-cell therapies
A next-generation CD33-directed ADC for AML
Unprecedented clinical trial results for MM
Myeloma highlights from ASCO 2017